Advertisement

Index by author

February 01, 1996; Volume 276,Issue 2

  1. L'hirondel, M

    1. Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum.
      A Chéramy, G Godeheu, M L'Hirondel and J Glowinski
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 616-625;

  2. Lago, A

    1. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
      E H Ohlstein, P Nambi, A Lago, D W Hay, G Beck, K L Fong, E P Eddy, P Smith, H Ellens and J D Elliott
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 609-615;

  3. Lai, C C

    1. Inhibition of cerebral neurogenic vasodilation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline.
      T J Lee, S Sarwinski, T Ishine, C C Lai and F Y Chen
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 353-358;

  4. Landais, L

    1. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
      A Bril, B Gout, M Bonhomme, L Landais, J F Faivre, P Linee, R H Poyser and R R Ruffolo
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 637-646;

  5. Lee, T J

    1. Inhibition of cerebral neurogenic vasodilation by L-glutamine and nitric oxide synthase inhibitors and its reversal by L-citrulline.
      T J Lee, S Sarwinski, T Ishine, C C Lai and F Y Chen
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 353-358;

  6. Lefevour, A

    1. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
      T S Shippenberg, A LeFevour and C Heidbreder
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 545-554;

  7. Levine, J D

    1. Differential contribution of descending controls to the antinociceptive actions of kappa and mu opioids: an analysis of formalin-evoked C-fos expression.
      K R Gogas, J D Levine and A I Basbaum
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 801-809;

  8. Lew, R

    1. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part I: Synaptosomal uptake and tissue concentrations.
      K E Sabol, R Lew, J B Richards, G L Vosmer and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 846-854;
    2. Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: Radioligand binding and autoradiography studies.
      R Lew, K E Sabol, C Chou, G L Vosmer, J Richards and L S Seiden
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 855-865;

  9. Li, B Y

    1. Characterization of the antinociceptive properties of cimetidine and a structural analog.
      B Y Li, J W Nalwalk, L A Barker, P Cumming, M E Parsons and L B Hough
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 500-508;

  10. Lichtman, A H

    1. Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.
      A H Lichtman, S A Cook and B R Martin
      Journal of Pharmacology and Experimental Therapeutics February 1996, 276 (2) 585-593;
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue

Advertisement